KYNB

MKT CAP:$28M

Kyntra Bio, Inc.

Market Cap

$28M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$6.71-$2.45 (-26.75%)

Jun 5, 2026

52W High $12.4352W Low $5.16

Company Details

Kyntra Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing FG-3246, a potential antibody-drug conjugate targeting CD46, for the treatme...

CEO

—

IPO Date

Nov 14, 2014

Website

www.kyntrabio.com

Key Metrics TTM

Revenue

$7M

+110.2% YoY

Net Income

$111M

EPS (Diluted)

Free Cash Flow

-$21M

Revenue / Share

$1.84

Gross Margin

35.1%

Operating Margin

-596.2%

Net Margin

1498.0%

FCF Margin

-287.7%

P/S

3.8x

P/E

0.3x

Earnings Reports

Q2 2026

Aug 10, 2026

PENDING

Q1 2026

May 12, 2026

$4M+36.5%

FY 2025

Mar 16, 2026

$6M-78.3%

Q4 2025

Mar 16, 2026

$1M+101.0%

Q3 2025

Nov 10, 2025

$1M-97.7%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee